Editorial
Published: 27 February, 2020 | Volume 4 - Issue 1 | Pages: 001-002
ystemic sclerosis (SScl) is an autoimmune disorder of unknown aetiology, characterised by fibrosis and microvascular injury of the affected organs. The hallmark of the disease is thickening and tightness of the skin and the subcutaneous tissue. SScl can affect virtually any organ systems, most importantly the skin, blood vessels, lungs, kidneys, gastrointestinal tract, and the heart [1].
Read Full Article HTML DOI: 10.29328/journal.jsctt.1001019 Cite this Article Read Full Article PDF
Autologous hematopoietic stem cell transplantation; Systemic sclerosis; Autoimmunity; Immunosuppression
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."